How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Viasat, TTP, and Frequentis conduct Iris Remotely Piloted Aircraft Systems (RPAS) trial: examining future satellite connectivity and traffic management integration for BVLOS operations within managed ...

Capcom has finally released a Resident Evil Requiem demo, allowing you to try its Game of the Year contender for free. Arriving three months after Resident Evil Requiem's February debut, this trial ...

The Visual Investigations team combines traditional reporting with digital sleuthing and the forensic analysis of visual evidence to find truth, hold the powerful to account and deconstruct important ...

We're celebrating 25 years of work to advance a bold vision for a just and inclusive democracy and economy that reflects a growing and diversifying nation. Read Taifa Smith Butler's reflection on ...

In the ever-evolving world of cryptocurrency trading, staying ahead of the curve is essential. As we look towards 2026, the landscape of crypto trading platforms is more dynamic than ever, offering ...

Greetings Radnor! We’re your go-to source for what’s happening in town. Read on to get plugged in! ☀️ Coming up on the calendar: ... and check out 17 more events on the calendar! Today's riddle: What ...

Modern warfare is changing fast. It is no longer just about who has the biggest tank or the fastest jet. The real advantage belongs to whoever can connect their entire military together instantly. A ...

Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.

The twist ending in Caro Claire Burke’s 'Yesteryear' has left readers divided and talking. Join our mostly spoiler-free discussion. Follow President Trump’s progress filling over 800 positions, among ...